Derivative Liabilities - Fair Value
Gilead Sciences Derivative Liabilities - Fair Value decreased by 40.0% to $24.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.0%, from $25.00M to $24.00M. Over 5 years (FY 2020 to FY 2025), Derivative Liabilities - Fair Value shows an upward trend with a 27.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in liabilities suggests unfavorable market movements for the company's hedges, while a decrease indicates a reduction in potential settlement obligations.
Detailed definition
This represents the fair value of derivative financial instruments that are currently in a liability position. These lia...
Peer comparison
Standard for energy companies; peers with similar hedging profiles will show comparable volatility in this line item.
derivative_liabilities_fair_valueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.00M | $7.00M | $4.00M | $9.00M | $3.00M | $2.00M | $36.00M | $24.00M | $19.00M | $8.00M | $7.00M | $8.00M | $2.00M | $7.00M | $3.00M | $25.00M | $7.00M | $29.00M | $40.00M | $24.00M |
| QoQ Change | — | -63.2% | -42.9% | +125.0% | -66.7% | -33.3% | >999% | -33.3% | -20.8% | -57.9% | -12.5% | +14.3% | -75.0% | +250.0% | -57.1% | +733.3% | -72.0% | +314.3% | +37.9% | -40.0% |
| YoY Change | — | — | — | — | -84.2% | -71.4% | +800.0% | +166.7% | +533.3% | +300.0% | -80.6% | -66.7% | -89.5% | -12.5% | -57.1% | +212.5% | +250.0% | +314.3% | >999% | -4.0% |
Derivative Liabilities - Fair Value at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's derivative liabilities - fair value?
- Gilead Sciences (GILD) reported derivative liabilities - fair value of $24.00M in Q1 2026.
- How has Gilead Sciences's derivative liabilities - fair value changed year-over-year?
- Gilead Sciences's derivative liabilities - fair value decreased by 4.0% year-over-year, from $25.00M to $24.00M.
- What is the long-term trend for Gilead Sciences's derivative liabilities - fair value?
- Over 5 years (2020 to 2025), Gilead Sciences's derivative liabilities - fair value has grown at a 27.2% compound annual growth rate (CAGR), from $12.00M to $40.00M.
- What does derivative liabilities - fair value mean?
- The total market value of all derivative contracts that are currently resulting in a loss.